Remove Communication Remove Packaging Remove Pharmaceutical Companies
article thumbnail

FOPE & PharmaState Academy host Session 12 of the PULSE series

Express Pharma

Jayakumar also spoke about the detailed procedures and SOPs needed for investigating market complaints and how these systems should be integrated into a companys overall quality management system.

article thumbnail

10 Innovative Trends in Pharma Marketing: Strategies for Industry Success in 2025

Pharma Marketing Network

Companies are investing heavily in digital tools to streamline communication and build stronger connections. Strategies like storytelling, personalized educational content, and two-way communication channels create trust and build loyalty. Patient-Centric Marketing Patients want to feel heard.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Eco-conscious packaging: A strategic opportunity

Express Pharma

The impact of packaging is felt only when it does not do its job and therefore pharmaceutical companies have traditionally invested quite a bit on product packs, also using them as part of their branding strategy. sq mm of material – there is more than 20 per cent reduction of packaging material. per cent CAGR.

Packaging 105
article thumbnail

Would the Industry Survive 200% Pharma Tariffs?

Pharma Marketing Network

Manufacturing Dependencies and Global Disruption Pharmaceutical manufacturing doesn’t operate within national borders. From packaging to proprietary coatings to the APIs themselves, nearly every prescription bottle represents a mosaic of global logistics. Even American-made branded drugs rely heavily on foreign-sourced components.

article thumbnail

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

Large pharmaceutical companies such as AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications, accounting for 63% of licensing deals between 2021 and 2025 year-to-date. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51

article thumbnail

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Pharmaceutical Technology

Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceutical company ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation. How will RFK Jr’s American dream for vaccines play out?

article thumbnail

UK government targets manufacturing as it eyes £41bn life science sector growth

Pharmaceutical Technology

The initiative comes at a crucial time, as British pharmaceutical companies are significantly increasing their investments in the United States. How will RFK Jr’s American dream for vaccines play out? GSK invested $800m in drug substance and drug product manufacturing facilities in the US in October 2024.